Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

PFE: Stock Quote & Summary Data

$ 16.46 0.06 0.37%
Sep. 3, 2010 Market Closed
Update Quotes: . Updates every 7 Seconds.
PFE
PFE | Pfizer, Inc. | Common Stock | Market : NYSE

Last Sale
Change Net / %
1y Target Est: $ 20.00
Today's High / Low  / 
Share Volume
Previous Close $ 16.40
52 Wk High / Low $ 20.36 / $ 14
Shares Outstanding 8,038,278,000
Market Value of Listed Security $ 132,310,055,880
P/E Ratio 7.41
Forward P/E (1yr) 7.24
Earnings Per Share $ 2.22
Annualized Dividend $0.720000
Ex Dividend Date Aug. 4, 2010
Dividend Payment Date Sep. 1, 2010
Current Yield 4.37 %
Beta 0.75

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About PFE?

Ask your question about about Pfizer, Inc. (PFE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

Pfizer Inc. (which may be referred to as Pfizer, the Company, we, us or our) is a research-based, global biopharmaceutical company. We apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer health care products. Every day, we work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  ... More ...  



 Company News for PFE Subscribe

A Fool Looks Back
- The Motley Fool  09/04/2010 8:34AM
Why You Just Got Hammered
- The Motley Fool  09/03/2010 6:55PM
FOCUS: Roche To Cut Costs As Austerity Programs, R&D Hurt
- Dow Jones Business News  09/03/2010 11:46AM
5-Star Stocks Poised to Pop: Gilead Sciences
- The Motley Fool  09/03/2010 10:50AM
Celldex, Pfizer Split Over Brain Tumor Drug
- TheStreet  09/03/2010 9:43AM

Read more PFE News & Commentary

 

Consensus Recommendation


Analyst Info

Annual EPS Est: $ 2.21
Quarterly EPS Est: $ 0.51
PEG Ratio: 3.65
Mean Recommendation:
View Summary/View All
2.00